Kumar Sambamurti to Technology, Pharmaceutical
This is a "connection" page, showing publications Kumar Sambamurti has written about Technology, Pharmaceutical.
Connection Strength
0.298
-
Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Curr Pharm Des. 2004; 10(25):3111-9.
Score: 0.241
-
A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr Drug Targets. 2003 Feb; 4(2):97-112.
Score: 0.057